April 2018 Issue of MMM
Caregivers and patients predict how the use of AI will affect them.
AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed
Industry opponents say the end is nigh for pharma's ability to deduct expenses for consumer drug advertising, but those who've found their calling in healthcare ...
Read the April 2018 issue in its entirety.
With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in ...
The 2017 numbers aren't kind to print-first publishers. Is this a blip in print's fortunes or the start of a long-predicted decline?
Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.
Marketers discuss the biggest catalysts for use of behavioral science techniques in marketing.
Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?
We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.
Angelina Sciolla, Ogilvy CommonHealth Worldwide VP and associate creative director, believes we've found more sophisticated ways to visualize illness and injury.
At Work With
Chris Palmer, president of CDM New York, shares his wake-up routine, what he's reading and his dream of owning a record store if he wasn't ...
PBMs began by providing a huge service to payers, but in recent years, they've begun to suck revenue from pharma manufacturers. Will they take some ...